Literature DB >> 2262557

Current concerns in haematology. 2: Classification of acute leukaemia.

B Bain1, D Catovsky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2262557      PMCID: PMC502894          DOI: 10.1136/jcp.43.11.882

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  36 in total

1.  A case of cALL relapse after allogeneic BMT: recurrence of recipient cell origin, initially determined as being that of donor cell origin by sex chromosome analysis.

Authors:  T Naoe; H Kiyoi; K Yamanaka; K Naito; K Yamada
Journal:  Br J Haematol       Date:  1989-11       Impact factor: 6.998

2.  Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.

Authors:  J J Shuster; J M Falletta; D J Pullen; W M Crist; G B Humphrey; B L Dowell; M D Wharam; M Borowitz
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

3.  Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia.

Authors:  C H Pui; F G Behm; B Singh; M J Schell; D L Williams; G K Rivera; D K Kalwinsky; J T Sandlund; W M Crist; S C Raimondi
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

4.  Prognostic implications of cytogenetic studies in an intensively treated group of children with acute lymphoblastic leukemia.

Authors:  J A Fletcher; V M Kimball; E Lynch; M Donnelly; K Pavelka; R D Gelber; R Tantravahi; S E Sallan
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

5.  Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 cases.

Authors:  P Fenaux; C Preudhomme; J L Laï; P Morel; R Beuscart; F Bauters
Journal:  Br J Haematol       Date:  1989-09       Impact factor: 6.998

6.  Diagnostic and prognostic significance of myelomonocytic cell surface antigens in acute myeloid leukaemia.

Authors:  H Merle-Beral; L Nguyen Cong Duc; V Leblond; C Boucheix; A Michel; C Chastang; P Debre
Journal:  Br J Haematol       Date:  1989-11       Impact factor: 6.998

7.  Human myeloperoxidase gene expression in acute leukemia.

Authors:  S R Zaki; G E Austin; D Swan; A Srinivasan; A H Ragab; W C Chan
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

8.  Prognostic importance of the pre-B-cell immunophenotype and other presenting features in B-lineage childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.

Authors:  W Crist; J Boyett; J Jackson; T Vietti; M Borowitz; A Chauvenet; N Winick; A Ragab; D Mahoney; D Head
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

9.  Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia.

Authors:  C D Bloomfield; L M Secker-Walker; A I Goldman; H Van Den Berghe; A de la Chapelle; T Ruutu; G Alimena; O M Garson; H M Golomb; J D Rowley
Journal:  Cancer Genet Cytogenet       Date:  1989-07-15

10.  Molecular analysis of acute undifferentiated leukemia: two distinct subgroups at the DNA and RNA levels.

Authors:  J Hara; K Yumura-Yagi; A Tawa; S Ishihara; M Murata; N Terada; Y Izumi; E Champagne; Y Takihara; T W Mak
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

View more
  3 in total

Review 1.  A classification of acute leukaemia for the 1990s.

Authors:  D Catovsky; E Matutes; V Buccheri; V Shetty; J Hanslip; N Yoshida; R Morilla
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

Review 2.  Routine and specialised techniques in the diagnosis of haematological neoplasms.

Authors:  B J Bain
Journal:  J Clin Pathol       Date:  1995-06       Impact factor: 3.411

3.  Heavy-chain immunoglobulin gene rearrangement and cytoplasmic immunoglobulin expression in acute monocytic leukemia following primary germ cell tumor.

Authors:  H T Greinix; C Beham-Schmid; H Silly; G Hoefler; A Kasparek; H L Seewann
Journal:  Ann Hematol       Date:  1995-02       Impact factor: 3.673

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.